2022 Speakers

These are the currently confirmed expert speakers for the
4th Allogeneic Cell Therapies Summit.

Get more information in the Full Event Guide.

Joanna Brewer

SVP Allogeneic Research

Adaptimmune

Blake Aftab

CSO

Adicet Bio

Donald Healy

CTO

Adicet Bio

Barbra Sasu

CSO

Allogene

Luke Pase

CTO

Anocca

Sven Kili

CEO

Antion Biosciences

Oscar Segurado

CMO

ASC Therapeutics

Pascal Touchon

CEO

Atara Biotherapeutics

Zhimei Du

VP, Process Sciences

Atara Biotherapeutics

James Glover

SVP, Commercial Manufacturing

Athersys

Maia Hansen

SVP & Head of Operations & Supply Chain

Athersys

Manal Morsy

SVP, Head of Global Regulatory Affairs

Athersys

Yuechen Zhu

Process Development Scientist

Bayer

Alden Ladd

Associate Director, Cellular Process Development

Beam Therapeutics

Chia-Hsing Pi

Scientist II, Process Development

BlueRock Therapeutics

Wendy Larson

Associate Director, Regulatory CMC Strategy

BlueRock Therapeutics

Katie Pollock

Head of Formulation & Cryobiology

BMS

Elizabeth Garner

Director, T Cell Therapeutics

Caribou Biosciences

Alan Trounson

CEO

Cartherics

Nicholas Boyd

Chief Development Officer

Cartherics

Joseph Gold

VP, Technical Operations & Manufacturing

Catamaran Bio

Vipin Suri

CSO

Catamaran Bio

Beatriz Aranda Orgilles

Senior Scientist & Team Leader, Immuno- Oncology

Cellectis

Carrie Brownstein

CMO

Cellectis

Bradley Glover

CTO

Celularity

Steven Doares

SVP US Manufacturing

Cellectis

David Gilham

CSO

Celyad Oncology

Stanley Frankel

CMO

Cytovia Therapeutics

Roman Shapiro

Attending Physician, Bone Marrow Transplantation

Dana-Faber Cancer Institute

Derek Dashti

CEO

D&P Bioinnovations

Erika von Euw

VP, Discovery and Translational Research

Deverra Therapeutics

Elena Spanjaard

VP, Early Development Regulatory Affairs

Elevate Bio

Oren Hershkovitz

CEO

Enlivex Therapeutics

Gregory Fiore

CEO

Exacis Therapeutics

Daniel Bright

Global Program Director, Global Technical Operations

Ferring Pharmaceuticals

Mahasweta Gooptu

Attending Physician & Assistant Professor of Medicine

Harvard Medical School

Hans Klingemann

CSO

ImmunityBio

Kate Rochlin

COO

IN8Bio

William Ho

CEO

IN8Bio

Austin Bigley

VP, Director of Research & Development

Indapta Therapeutics

Christopher Ballas

SVP, Manufacturing

Innovative Cellular Therapeutics

Arik Hasson

Executive VP, Research & Development

Kadimastem

Evren Alici

Head of Cell & Gene Therapy

Karolinska Institute

Brian Culley

CEO

Lineage Cell Therapeutics

Silviu Itescu

CEO

Mesoblast

Mark Exley

SAB Member & Senior Advisor

MiNK Therapeutics

Carl Simon

Biologist

National Institute of Standards & Technology

Sumona Sarkar

Biomedical Engineer

National Institute of Standards & Technology

Ralph Brandenberger

VP, Development & Manufacturing

Nkarta Therapeutics

Stephen Chen

CTO & COO

NKGen Biotech

Emily Titus

VP, Process Sciences

Notch Therapeutics

Eric Halioua

CEO

PDC*Line Pharma

Lior Raviv

CTO

Pluristem Therapeutics

Greg Whitehead

Chief Quality Officer

Rubius Therapeutics

Spencer Fisk

SVP & CTOO

Rubius Therapeutics

Sonja Schrepfer

SVP, Head of Hypo- Immune Platform

Sana Biotechnology

Tim Jansen

Director, Product Supply Chain Lead

Sana Biotechnology

Gary Lee

CSO

Senti Biosciences

Martin Giedlin

VP, Head of Technical Operations

Senti Biosciences

Amy McCord

Director, Global Regulatory Affairs, CMC Cell Therapy

Takeda

Benjamin Gysi

Director, Cell Therapy Operations

Takeda

Michael Leek

Co-Founder & Executive Chairman

TC BioPharm

Rakibou Ouro- Djobo

Associate Director, Clinical Supply Chain

TCR2 Therapeutics

Peggy Sotiropoulou

CSO

T-Knife Therapeutics

Jason Acker

Professor, Department of Laboratory Medicine & Pathology

University of Alberta

Allison Hubel

Professor, Department of Mechanical Engineering & Director, Technological Leadership Institute

University of Minnesota

James Ankrum

Associate Professor, Biomedical Engineering

University of Iowa

Brian Van Tine

Professor, Medicine & Pediatrics

Washington University School of Medicine in St. Louis

Rong Fan

Professor, Biomedical Engineering

Yale University

Luise Weigand

Head of Research

Zelluna Immunotherapy